RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 115 filers reported holding RELAY THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,712,393 | -32.9% | 322,520 | +0.2% | 0.00% | 0.0% |
| Q2 2023 | $4,041,319 | -34.7% | 321,761 | -14.4% | 0.00% | 0.0% |
| Q1 2023 | $6,192,736 | +6.7% | 376,001 | -3.2% | 0.00% | 0.0% |
| Q4 2022 | $5,803,966 | -24.2% | 388,485 | +13.5% | 0.00% | -50.0% |
| Q3 2022 | $7,656,000 | +53.6% | 342,252 | +15.0% | 0.00% | +100.0% |
| Q2 2022 | $4,985,000 | -41.9% | 297,616 | +3.7% | 0.00% | -50.0% |
| Q1 2022 | $8,586,000 | -0.5% | 286,886 | +2.1% | 0.00% | 0.0% |
| Q4 2021 | $8,628,000 | +16.5% | 280,928 | +19.6% | 0.00% | +100.0% |
| Q3 2021 | $7,406,000 | +20.9% | 234,882 | +40.3% | 0.00% | 0.0% |
| Q2 2021 | $6,124,000 | +27.6% | 167,373 | +20.5% | 0.00% | 0.0% |
| Q1 2021 | $4,801,000 | -0.3% | 138,865 | +19.9% | 0.00% | 0.0% |
| Q4 2020 | $4,814,000 | +26.9% | 115,854 | +30.1% | 0.00% | 0.0% |
| Q3 2020 | $3,793,000 | – | 89,053 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 6,923,574 | $58,227,257 | 6.44% |
| Finepoint Capital LP | 870,870 | $7,324,017 | 3.65% |
| Nextech Invest Ltd. | 1,196,409 | $10,061,800 | 3.05% |
| MPM BioImpact LLC | 1,352,133 | $11,371,439 | 3.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $234,680,739 | 1.93% |
| EcoR1 Capital, LLC | 4,163,824 | $35,017,760 | 1.18% |
| Integral Health Asset Management, LLC | 800,000 | $6,728,000 | 0.93% |
| Alphabet Inc. | 1,568,753 | $13,193,212 | 0.85% |
| HARBOURVEST PARTNERS LLC | 296,402 | $2,492,741 | 0.85% |
| Boxer Capital, LLC | 1,819,132 | $15,298,900 | 0.81% |